Apellis Pharmaceuticals, Inc. (APLS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Core Viewpoint - Apellis Pharmaceuticals, Inc. (APLS) is currently under investigation by Bronstein, Gewirtz & Grossman, LLC, which is encouraging investors to reach out for more information regarding the investigation [1] Group 1 - The investigation pertains to potential securities violations by Apellis Pharmaceuticals [1] - Investors are being urged to contact the firm to learn more about the implications of the investigation [1] - The investigation may impact investor confidence and the company's stock performance [1]